A strategic partnership between Vaxxas and Profenso, an Australian AI company specialising in advanced automation for regulated industries, has been announced.

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers. The life sciences tools and ...

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.

When analyzing the drug delivery product pipeline, three key technologies stand out. Check out the latest market research.